Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page Not Available ()Premium Content



2015-03-26@08:00:00 ET
Shire and Cincinnati Children's Establish Rare Disease Research Collaboration (PRN)

2015-03-25@18:12:44 ET
Shire announces availability of new titration strength of ADHD drug (DTM)

2015-03-19@16:23:02 ET
TherapeuticsMD Appoints Biopharmaceutical Senior Executives Angus C. Russell and J. Martin Carroll as Independent Directors (ABW)

2015-03-18@08:49:34 ET
Leukodystrophies Therapeutics Pipeline Review 2015 - 6 Companies & 6 Drug Profiles (MTO)

2015-03-18@08:00:01 ET
TherapeuticsMD Appoints Biopharmaceutical Senior Executives Angus C. Russell and J. Martin Carroll as Independent Directors (BIZ)

2015-03-11@02:44:59 ET
Shire submits NDA to FDA for treatment of dry eye disease in adults (DTM)

2015-03-10@11:17:23 ET
8-K: Shire plc (EDK)

2015-03-06@07:10:33 ET
Shire Submits NDA for Dry Eye Disease Drug Lifitegrast (ZAX)

2015-03-05@15:56:04 ET
Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. (ABW)

2015-03-04@17:17:27 ET
8-K: Shire plc (EDK)

2015-03-04@07:28:20 ET
Global Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Pipeline Review 2015 - 20 Drug Profiles & 15 Companies (MTO)

2015-03-03@16:29:52 ET
8-K: Shire plc (EDK)

2015-03-03@07:34:52 ET
Primary Biliary Cirrhosis Therapeutics Pipeline Review 2015 - 9 Companies & 10 Drug Profiles (MTO)

2015-03-03@07:24:19 ET
Constipation Therapeutics Pipeline Review 2015 - 18 Drug Profiles & 20 Drug Profiles (MTO)

2015-03-03@06:10:24 ET
Non-Alcoholic Steatohepatitis Therapeutics Pipeline Review 2015 - Analysis of 32 Companies & 53 Drug Profiles (MTO)

2015-03-02@16:14:00 ET
8-K: Shire plc (EDK)

2015-03-02@07:02:34 ET
Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults (EUR)

2015-03-02@07:00:00 ET
Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults (PRN)

2015-02-26@17:00:07 ET
Revance Appoints Dr. Philip Vickers to Its Board of Directors (PMZ)

2015-02-26@06:55:19 ET
Diarrhea Therapeutics Pipeline Review 2015 - 31 Companies Developing 35 Drug Profiles (MTO)